Scarica l'app Stockscreener
10.59
0.09%
-0.010
Precedente Chiudi:
$10.60
Aprire:
$10.61
Volume 24 ore:
1,083
Relative Volume:
0.01
Capitalizzazione di mercato:
$257.09M
Reddito:
-
Utile/perdita netta:
$5.94M
Rapporto P/E:
59.76
EPS:
0.1772
Flusso di cassa netto:
$-539.20K
1 W Prestazione:
+0.09%
1M Prestazione:
+0.43%
6M Prestazione:
+2.52%
1 anno Prestazione:
+4.54%
Intervallo 1D:
$10.59
$10.61
Intervallo di 1 settimana:
$10.59
$10.61
Portata 52W:
$10.12
$10.61
Drugs Made In America Acquisition Corp Stock (DMAA) Company Profile
Nome
Drugs Made In America Acquisition Corp
Settore
Industria
Telefono
646-726-7074
Indirizzo
420 LEXINGTON AVENUE, NEW YORK
Compare DMAA vs LION, XXI, UMAC, DMII, BCSS
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
DMAA
Drugs Made In America Acquisition Corp
|
10.59 | 257.34M | 0 | 5.94M | -539.20K | 0.1772 |
LION
Lionsgate Studios Corp
|
14.38 | 4.34B | 2.80B | -224.60M | -1.10M | -0.8751 |
XXI
Twenty One Capital Inc
|
7.285 | 2.54B | 0 | 4.35M | 456.40K | 0.3397 |
UMAC
Unusual Machines Inc
|
17.87 | 801.98M | 11.20M | -19.19M | -23.24M | -0.7527 |
DMII
Drugs Made In America Acquisition Ii Corp
|
10.06 | 640.82M | 0 | 4.19M | 0 | 0.065 |
BCSS
Bain Capital Gss Investment Corp
|
10.19 | 595.10M | 0 | 0 | 0 | 0.0729 |
Drugs Made In America Acquisition Corp Borsa (DMAA) Ultime notizie
PTACU|Patriot Acquisition Units (Proposed)|Price:9.950|Chg%:-0.01 - TradingKey
symbol__ Stock Quote Price and Forecast - CNN
DMAA SEC FilingsDrugs Made In Amer Acqutn Corp 10-K, 10-Q, 8-K Forms - Stock Titan
TradingKey - TradingKey
HEIGHTS CAPITAL MANAGEMENT, INC's Drugs Made In America Acquisition II Corp(DMIIU) Holding History - GuruFocus
Shutterstock, Inc. 8-K Filing: UK CMA Approves Merger with Getty Images Holdings, Inc - Minichart
Number of shareholders of Drugs Made In America Acquisition II Corp. – NASDAQ:DMII - TradingView
DMAA Price Today: Drugs Made In America Acquisition Corp. Stock Price, Quote & Chart | MEXC - MEXC
Drugs Made In America Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
[10-Q] Drugs Made In America Acquisition Corp. Quarterly Earnings Report - Stock Titan
Drugs Made In America Acquisition II Corp. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Drugs Made in America II (DMII) Q1 profit from trust interest amid going-concern risk - Stock Titan
Mizuho Financial Group reports 2,000,000 DMAA shares (DMAA) on 05/14/2026 - Stock Titan
Mercuria Capital Strategies, LLC's Drugs Made In America Acquisition Corp(DMAA) Holding History - GuruFocus
Number of shareholders of Drugs Made In America Acquisition Corp. – NASDAQ:DMAA - TradingView
'Drugs Made In America' SPAC Eyes $1B Deal With AI Platform - Law360
Drugs Made In America Acquisition Corp (DMAA) and Power Analytics Global Corp Announce Definitive $1B AI Merger Agreement - Minichart
Drugs Made In America Acquisition Announces PAGC Merger Deal - TipRanks
Drugs Made In America Acquisition to Merge With Power Analytics Global in Deal Valued Up to $1 Billion - TradingView
DMAA (NASDAQ: DMAA) to combine with Power Analytics Global; $1.0B target valuation - Stock Titan
DMAA (NASDAQ: DMAA) sets $1.0B PAGC merger with 90/10 ownership split - Stock Titan
Leadership Compensation Aligned With Future Business Combination - TipRanks
Shareholders Approve Extension of SPAC Business Combination Deadline - The Globe and Mail
DMAA Corp Extends Business Combination Deadline to April 29, 2027 Following Shareholder Approval – SEC 8-K Filing Update - Minichart
Drugs Made in America (NASDAQ: DMAA) holders redeem $99M from SPAC trust - Stock Titan
QLEP_u|Quantum Leap Acquisition Units (Proposed)|Price:10.006|Chg%:0.01 - TradingKey
Talon Resources plc: Shareholders Board Members Managers and Company Profile | GB00BM8SQP62 - marketscreener.com
Drugs Made In America Acquisition Updates Executive Compensation Agreements - The Globe and Mail
Drugs Made In America Acquisition II Corp. Updates CFO and CEO Compensation Agreements and Share Grant Terms - Minichart
[8-K] Drugs Made In America Acquisition II Corp. Reports Material Event - Stock Titan
Drugs Made in America (NASDAQ: DMAA) details new CEO pay deal - Stock Titan
AmericanDrug (DMAAR) Stock: This Week (-4.28%) 2026-04-27Macro Trends - Newser
ETFs Investing in Drugs Made In America Acquisition II Corp. Stocks - TradingView
Short Interest in Drugs Made In America Acquisition Corp. (NASDAQ:DMAA) Grows By 8,397.5% - MarketBeat
DMAA | Drugs Made In America Insider Trading - Quiver Quantitative
Illumination Acquisition Corp I: Performance & Quotes, ILLU Stock Price on Nasdaq Exchange - marketscreener.com
DMII Price History for Drugs Made IN America Acquisition II Stock - Barchart.com
DMAAR Price History for Drugs Made IN America Acquisition Corp. Rights Stock - Barchart.com
USDrugAcqII (DMIIU) Stock Mutual Fund Trade (+0.10%) 2026-04-20Market Hype - Cổng thông tin điện tử tỉnh Lào Cai
AmDrug Acq2 (DMII) Stock: Is It a Compelling Buy (Idled) 2026-04-20Rating Change - Cổng thông tin điện tử tỉnh Lào Cai
Is AmericanDrug (DMAAR) stock exposed to downside risk (Selloff Intensifies) 2026-04-20Company Analysis - Cổng thông tin điện tử tỉnh Lào Cai
The top 20 pharma companies by 2025 revenue - Fierce Pharma
US Drug Acq (DMAA) Stock Upgrade Alert (Stuck) 2026-04-18Expert Breakout Alerts - Xã Châu Thành
JATT|JATT II Acquisition Ord Shs|Price:10.500| - TradingKey
Drugs Made In America Acquisition Corp.: Valuation Ratios, Analysts' Forecasts - marketscreener.com
Vote math updated for Drugs Made In America (DMAA) in proxy amendment - Stock Titan
Drugs Made In America Acquisition II Corp. 10-K Annual Report: Business Strategy, Acquisition Focus, and Management Overview - Minichart
Drugs Made In America Acquisition Corp. (DMAA): SPAC Focusing on AI, Machine Learning, and Pharmaceutical Acquisition Opportunities - Minichart
Drugs Made In America Acquisition Corp. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Drugs Made In America (NASDAQ: DMAA) details SPAC cash, LOI and risks - Stock Titan
Drugs Made In America Acquisition II Corp. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Drugs Made In America Acquisition Corp Azioni (DMAA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.00%
1.90%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):